![Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery | Journal of the American Chemical Society Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/ja211589m/asset/images/medium/ja-2011-11589m_0002.gif)
Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery | Journal of the American Chemical Society
Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery | Journal of the American Chemical Society
![Cancers | Free Full-Text | L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model Cancers | Free Full-Text | L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model](https://www.mdpi.com/cancers/cancers-11-01232/article_deploy/html/images/cancers-11-01232-g001.png)
Cancers | Free Full-Text | L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
![Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin - Borsi - 2002 - International Journal of Cancer - Wiley Online Library Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin - Borsi - 2002 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6a1183a9-b2c6-4662-a3e1-6951b84c9a4c/mfig001.jpg)